FibroGen, Inc. (FGEN)
NASDAQ: FGEN · IEX Real-Time Price · USD
0.971
-0.014 (-1.38%)
Apr 25, 2024, 11:32 AM EDT - Market open
FibroGen Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 147.75 | 140.73 | 235.31 | 176.32 | 256.58 | 212.96 | 131 | 183.19 | 180.83 | 137.6 | Upgrade
|
| Revenue Growth (YoY) | 4.99% | -40.19% | 33.46% | -31.28% | 20.48% | 62.57% | -28.49% | 1.31% | 31.41% | 34.68% | Upgrade
|
| Cost of Revenue | 18.85 | 20.28 | 12.87 | 8.87 | 1.15 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Gross Profit | 128.9 | 120.45 | 222.44 | 167.45 | 255.43 | 212.96 | 131 | 183.19 | 180.83 | 137.6 | Upgrade
|
| Selling, General & Admin | 115.25 | 124.69 | 123.93 | 106.41 | 135.48 | 63.81 | 51.76 | 46.03 | 44.36 | 36.91 | Upgrade
|
| Research & Development | 282.86 | 296.79 | 387.04 | 252.92 | 209.27 | 235.84 | 196.52 | 187.21 | 214.09 | 150.79 | Upgrade
|
| Other Operating Expenses | 12.61 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Operating Expenses | 410.72 | 421.48 | 510.97 | 359.33 | 344.74 | 299.65 | 248.28 | 233.23 | 258.45 | 187.7 | Upgrade
|
| Operating Income | -281.82 | -301.03 | -288.53 | -191.88 | -89.31 | -86.69 | -117.28 | -50.04 | -77.63 | -50.1 | Upgrade
|
| Interest Expense / Income | 15.53 | 1.44 | 1.08 | 2.4 | 2.88 | 10.99 | 9.71 | 10.73 | 11.03 | 11.11 | Upgrade
|
| Other Expense / Income | -13.12 | -9.17 | 0.07 | -5.35 | -15.55 | -11.57 | -6.43 | -2.63 | -3.12 | -1.71 | Upgrade
|
| Pretax Income | -284.23 | -293.3 | -289.68 | -188.93 | -76.64 | -86.12 | -120.55 | -58.14 | -85.54 | -59.5 | Upgrade
|
| Income Tax | 0 | 0.36 | 0.35 | 0.36 | 0.33 | 0.3 | 0.32 | -0.07 | 0.24 | 0 | Upgrade
|
| Net Income | -284.23 | -293.65 | -290.02 | -189.29 | -76.97 | -86.42 | -120.88 | -58.07 | -85.78 | -59.5 | Upgrade
|
| Shares Outstanding (Basic) | 97 | 94 | 92 | 90 | 87 | 84 | 73 | 63 | 60 | 19 | Upgrade
|
| Shares Outstanding (Diluted) | 97 | 94 | 92 | 90 | 87 | 84 | 73 | 63 | 60 | 19 | Upgrade
|
| Shares Change | 3.98% | 1.34% | 2.78% | 3.72% | 3.06% | 15.17% | 16.33% | 3.99% | 221.37% | 42.39% | Upgrade
|
| EPS (Basic) | -2.92 | -3.14 | -3.14 | -2.11 | -0.89 | -1.03 | -1.66 | -0.93 | -1.42 | -3.17 | Upgrade
|
| EPS (Diluted) | -2.92 | -3.14 | -3.14 | -2.11 | -0.89 | -1.03 | -1.66 | -0.93 | -1.42 | -3.17 | Upgrade
|
| Free Cash Flow | -317.54 | -149.67 | -87.42 | 77.61 | -84.46 | -83.98 | -75.01 | 5.86 | -20.55 | 14.31 | Upgrade
|
| Free Cash Flow Per Share | -3.26 | -1.60 | -0.95 | 0.86 | -0.97 | -1.00 | -1.03 | 0.09 | -0.34 | 0.76 | Upgrade
|
| Gross Margin | 87.24% | 85.59% | 94.53% | 94.97% | 99.55% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | Upgrade
|
| Operating Margin | -190.74% | -213.90% | -122.62% | -108.83% | -34.81% | -40.71% | -89.53% | -27.32% | -42.93% | -36.41% | Upgrade
|
| Profit Margin | -192.37% | -208.66% | -123.25% | -107.36% | -30.00% | -40.58% | -92.27% | -31.70% | -47.44% | -43.24% | Upgrade
|
| Free Cash Flow Margin | -214.91% | -106.35% | -37.15% | 44.02% | -32.92% | -39.44% | -57.26% | 3.20% | -11.36% | 10.40% | Upgrade
|
| EBITDA | -258.77 | -281.25 | -273.79 | -164.48 | -52.31 | -68.56 | -104.75 | -41.37 | -68.83 | -43.93 | Upgrade
|
| EBITDA Margin | -175.14% | -199.85% | -116.35% | -93.29% | -20.39% | -32.20% | -79.96% | -22.59% | -38.06% | -31.92% | Upgrade
|
| Depreciation & Amortization | 9.93 | 10.6 | 14.81 | 22.05 | 21.45 | 6.56 | 6.1 | 6.04 | 5.68 | 4.47 | Upgrade
|
| EBIT | -268.7 | -291.86 | -288.6 | -186.53 | -73.77 | -75.13 | -110.85 | -47.41 | -74.5 | -48.4 | Upgrade
|
| EBIT Margin | -181.86% | -207.38% | -122.65% | -105.79% | -28.75% | -35.28% | -84.62% | -25.88% | -41.20% | -35.17% | Upgrade
|